Emm, the UK‑based femtech startup developing what it describes as one of the world’s first smart menstrual cups, has raised an oversubscribed Seed round of $9 million, led by Lunar Ventures, the company announced recently. This positions Emm among Europe’s most notable early‑stage femtech raises in 2025, according to independent reporting.
Funding Details and Investors
Multiple sources confirm that Emm’s Seed round totaled approximately $9 million (or €7.7 million / £6.8 million), led by Lunar Ventures, with participation from Labcorp Venture Fund, BlueLion Global, Alumni Ventures, and angel investors including Amar Shah, Vivek Garipalli, and Harpreet Rai, among others.
Public reporting emphasizes the round’s oversubscribed nature and notes that non‑dilutive grants also support Emm’s development efforts.
Product and Launch Timeline
Emm’s product is a menstrual cup made of medical‑grade silicone embedded with ultra‑thin sensor technology to monitor menstrual flow, cycle patterns, and volume via a connected app. The device has been under development for around five years, involving extensive design iterations and extended user testing. Emm plans a UK consumer launch in early 2026, with a waitlist already open.
Significance
This raise and product represent a rare convergence of hardware innovation, femtech, and reproductive health data. It aims to bring menstrual health tracking into parity with cardiovascular or metabolic metrics—a shift industry observers view as potentially transformative for women’s health diagnostics and self‑advocacy.
Conclusion
By securing substantial Seed funding and positioning a novel biowearable for menstrual health, Emm is gaining visibility and momentum. Its upcoming UK launch in early 2026 will be a key milestone to watch in femtech innovation.